|Articles|March 10, 2022
Survey: Pandemic impact on consumer trust in biopharma
Author(s)Reverba
The biopharma industry launched COVID vaccines and treatments in record time. How did this impact consumer trust? We asked, and compared survey results with 2017 data.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Related Content
Trending on PharmExec
1
Relation Therapeutics Forms $1.7 Billion Multi-Program Collaboration with Novartis Advancing Therapeutics for Atopic Diseases
2
Augmentin XR Becomes First Approval Under Commissioner’s National Priority Voucher Pilot Program
3
Pfizer Enters Exclusive Collaboration and License Agreement with Yao Pharma for Oral Small-Molecule GLP-1 Agonists
4
FDA Approves Waskyra For Treatment of Wiskott-Aldrich Syndrome
5
